[Beta-receptor blockaders and asthma bronchiale].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D011299:Prenylamine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014700:Verapamil; D011299:Prenylamine
Beta-Rezeptoren-Blocker und Asthma bronchiale.